This is a StreetInsider.com Premium Only Page

(ETTX) –

Oct 12, 2022 08:30 AM Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022

Jul 21, 2022 05:28 PM Form 15-12G Entasis Therapeutics

Jul 13, 2022 09:28 PM Form 4 Entasis Therapeutics For: Jul 08 Filed by: Innoviva, Inc.

Jul 13, 2022 06:03 AM Form EFFECT Entasis Therapeutics

Jul 13, 2022 06:03 AM Form EFFECT Entasis Therapeutics

Jul 13, 2022 06:03 AM Form EFFECT Entasis Therapeutics

Jul 13, 2022 06:03 AM Form EFFECT Entasis Therapeutics

Jul 11, 2022 05:27 PM Form SC 13D/A Entasis Therapeutics Filed by: Innoviva, Inc.

Jul 11, 2022 05:19 PM Form S-8 POS Entasis Therapeutics

Jul 11, 2022 05:18 PM Form S-8 POS Entasis Therapeutics

Jul 11, 2022 05:17 PM Form S-8 POS Entasis Therapeutics

Jul 11, 2022 05:17 PM Form S-8 POS Entasis Therapeutics

Jul 11, 2022 05:16 PM Form S-8 POS Entasis Therapeutics

Jul 11, 2022 05:15 PM Form S-8 POS Entasis Therapeutics

Jul 11, 2022 05:13 PM Form POS AM Entasis Therapeutics

Jul 11, 2022 05:13 PM Form POS AM Entasis Therapeutics

Jul 11, 2022 05:12 PM Form POS AM Entasis Therapeutics

Jul 11, 2022 05:08 PM Form POS AM Entasis Therapeutics

Jul 11, 2022 05:02 PM Form 8-K Entasis Therapeutics For: Jul 07

Jul 11, 2022 04:11 PM Form 4 Entasis Therapeutics For: Jul 11 Filed by: Wagner Kristie Ann

Jul 11, 2022 04:10 PM Form 4 Entasis Therapeutics For: Jul 11 Filed by: Triola Anna Diaz

Jul 11, 2022 04:10 PM Form 4 Entasis Therapeutics For: Jul 07 Filed by: Tommasi Ruben

Jul 11, 2022 04:09 PM Form 4 Entasis Therapeutics For: Jul 07 Filed by: Ronsheim Matthew

Jul 11, 2022 04:08 PM Form 4 Entasis Therapeutics For: Jul 07 Filed by: Mueller John Patrick

Jul 11, 2022 04:08 PM Form 4 Entasis Therapeutics For: Jul 07 Filed by: Perros Manoussos

Jul 11, 2022 04:07 PM Form 4 Entasis Therapeutics For: Jul 07 Filed by: Meek David D.

Jul 11, 2022 04:07 PM Form 4 Entasis Therapeutics For: Jul 07 Filed by: Mayer Howard

Jul 11, 2022 04:06 PM Form 4 Entasis Therapeutics For: Jul 07 Filed by: Keiley Elizabeth M

Jul 11, 2022 04:05 PM Form 4 Entasis Therapeutics For: Jul 07 Filed by: Berger Heather A.

Jul 11, 2022 04:05 PM Form 4 Entasis Therapeutics For: Jul 07 Filed by: HASTINGS DAVID C

Jul 11, 2022 04:04 PM Form 4 Entasis Therapeutics For: Jul 07 Filed by: Altarac David

Jul 11, 2022 11:02 AM Form 25-NSE Entasis Therapeutics Filed by: Nasdaq Stock Market LLC

Jul 8, 2022 05:05 PM Form SC 13E3/A Entasis Therapeutics Filed by: Entasis Therapeutics Holdings Inc.

Jul 8, 2022 05:02 PM Form SC 14D9/A Entasis Therapeutics Filed by: Entasis Therapeutics Holdings Inc.

Jul 8, 2022 04:55 PM Form SC 13E3/A Entasis Therapeutics Filed by: Innoviva, Inc.

Jul 8, 2022 04:49 PM Form SC TO-T/A Entasis Therapeutics Filed by: Innoviva, Inc.

Jul 8, 2022 08:35 AM Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.

Jul 1, 2022 06:04 AM Form SC 14D9/A Entasis Therapeutics Filed by: Entasis Therapeutics Holdings Inc.

Jun 17, 2022 08:11 AM Form SC 13E3/A Entasis Therapeutics Filed by: Entasis Therapeutics Holdings Inc.

Jun 17, 2022 08:09 AM Form SC 14D9/A Entasis Therapeutics Filed by: Entasis Therapeutics Holdings Inc.

Jun 17, 2022 08:04 AM Form SC 13E3/A Entasis Therapeutics Filed by: Innoviva, Inc.

Jun 17, 2022 07:58 AM Form SC TO-T/A Entasis Therapeutics Filed by: Innoviva, Inc.

Jun 9, 2022 08:01 AM Entasis Therapeutics Holdings Inc. (ETTX) Presents Data on Sulbactam-Durlobactam and ETX0462

Jun 9, 2022 08:00 AM Entasis Therapeutics Presents Data on Sulbactam-Durlobactam and ETX0462 at 2022 ASM Microbe Annual Conference

Jun 9, 2022 08:00 AM Entasis Therapeutics Presents Data on Sulbactam-Durlobactam and ETX0462 at 2022 ASM Microbe Annual Conference

Jun 7, 2022 09:23 AM Form SC 13E3 Entasis Therapeutics Filed by: Entasis Therapeutics Holdings Inc.

Jun 7, 2022 09:20 AM Form SC 13E3 Entasis Therapeutics Filed by: Innoviva, Inc.

Jun 7, 2022 09:12 AM Form SC 14D9 Entasis Therapeutics Filed by: Entasis Therapeutics Holdings Inc.

Jun 7, 2022 09:05 AM Form SC TO-T Entasis Therapeutics Filed by: Innoviva, Inc.

May 24, 2022 04:04 PM ENTASIS ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of ETTX and Encourages Investors to Contact the Firm